A Rheumatoid Arthritis programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €4,640–€46,400 in the United Kingdom. About 3.2h from London, inside the EU, visa-free.
If you are researching Rheumatoid Arthritis treatment from the United Kingdom, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €4,640–€46,400. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Rheumatoid arthritis is a chronic autoimmune condition where the immune system erroneously attacks joint synovium, causing inflammation, cartilage degradation, and bone erosion. Stem-cell investigations, primarily using placental mesenchymal stem cells, explore whether these cells can modulate the underlying immune dysregulation and reduce synovial inflammation. MSCs secrete immunosuppressive cytokines and may shift macrophage polarisation from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes. With 43 registered trials and 7 currently recruiting, the therapeutic premise differs from muscular dystrophy: rather than direct tissue regeneration, MSCs aim to suppress the aberrant T-cell and B-cell responses driving the disease. Early clinical data suggest potential for joint-specific injection or systemic administration to reduce disease activity scores and inflammation markers. It is delivered under a physician-led protocol and designed to complement your existing care.
| United Kingdom (home) | Stem Plus · EU | |
|---|---|---|
| Rheumatoid Arthritis treatment | €4,640–€46,400 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 3.2h from London | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite